Cargando…

Alpha-1-proteinase inhibitor regulates CD4 lymphocyte levels and is rate limiting in HIV-1 disease

Detalles Bibliográficos
Autores principales:	Bristow, Cynthia L, Babayeva, Mariya A, Labrunda, Michelle, Mullen, Michael P, Cortes, Jose, Winston, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360269/ http://dx.doi.org/10.1186/1742-4690-9-S1-P23

Ejemplares similares

α(1)Proteinase Inhibitor Regulates CD4(+) Lymphocyte Levels and Is Rate Limiting in HIV-1 Disease
por: Bristow, Cynthia L., et al.
Publicado: (2012)

Rapid cell-free CD4 enumeration using whole saliva
por: Bristow, Cynthia L, et al.
Publicado: (2012)

Limited proteolysis by macrophage elastase inactivates human alpha 1- proteinase inhibitor
Publicado: (1980)

Development of Immature CD4(+)CD8(+)T Cells Into Mature CD4(+) T Cells Requires Alpha-1 Antitrypsin as Observed by Treatment in HIV-1 Infected and Uninfected Controls
por: Bristow, Cynthia L., et al.
Publicado: (2019)

Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases
Publicado: (1988)

Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans
por: Bristow, Cynthia L., et al.
Publicado: (2021)

Lipopolysaccharide modulates the expression of alpha 1 proteinase inhibitor and other serine proteinase inhibitors in human monocytes and macrophages
Publicado: (1987)

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
por: Chotirmall, Sanjay H, et al.
Publicado: (2015)

Hypersensitivity Vasculitis with Leukocytoclastic Vasculitis Associated with Alpha-1-Proteinase Inhibitor
por: Mwirigi, Nicola W., et al.
Publicado: (2009)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
por: Buck, Emanuel, et al.
Publicado: (2022)

Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4(+) T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis
por: Bristow, Cynthia L., et al.
Publicado: (2021)

Restrictions to HIV-1 replication in resting CD4(+) T lymphocytes
por: Fackler, Oliver
Publicado: (2013)

Lung deposition of inhaled Alpha-1-proteinase inhibitor (Alpha(1)-PI) - problems and experience of Alpha(1)-PI inhalation therapy in patients with hereditary Alpha(1)-PI deficiency and cystic fibrosis
por: Siekmeier, R
Publicado: (2010)

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature
por: Parr, David G, et al.
Publicado: (2017)

Serum activity of joint destruction proteinases in management of juvenile rheumatoid arthritis
por: Yarygina, E, et al.
Publicado: (2003)

The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant
Publicado: (1988)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
por: Rahaghi, Franck F., et al.
Publicado: (2017)

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes
por: Su, B, et al.
Publicado: (2012)

The Emerging Threat of Ebola
por: LaBrunda, Michelle, et al.
Publicado: (2019)

Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition
por: Roddick, Leigh Ann, et al.
Publicado: (2013)

Arterivirus Papain-like Proteinase 1β
por: Nedialkova, Danny D., et al.
Publicado: (2013)

Arterivirus Papain-like Proteinase 1α
por: Nedialkova, Danny D., et al.
Publicado: (2013)

Proteinases in the joint: clinical relevance of proteinases in joint destruction
por: Rengel, Yvonne, et al.
Publicado: (2007)

Characterization of the CD177 interaction with the ANCA antigen proteinase 3
por: Jerke, Uwe, et al.
Publicado: (2017)

Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes
por: Zhou, Xueyuan, et al.
Publicado: (2016)

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
por: Hulot, SL, et al.
Publicado: (2012)

Vpr content of HIV-1 virions determines infection of resting peripheral blood CD4(+) lymphocytes
por: Van Nuffel, Anouk, et al.
Publicado: (2013)

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
por: Stolk, Jan, et al.
Publicado: (2005)

Implantation Serine Proteinase 1 Exhibits Mixed Substrate Specificity that Silences Signaling via Proteinase-Activated Receptors
por: Sharma, Navneet, et al.
Publicado: (2011)

In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules
Publicado: (1976)

Cytosolic, Autocrine Alpha-1 Proteinase Inhibitor (A1PI) Inhibits Caspase-1 and Blocks IL-1β Dependent Cytokine Release in Monocytes
por: Wang, Yonggang, et al.
Publicado: (2012)

Relationship between the sialylation level of anti-proteinase 3 antibodies and the activity of granulomatosis with polyangiitis (Wegener’s disease)
por: Guilpain, Philippe, et al.
Publicado: (2011)

Decreased peripheral CD4(+)/CD8(+ )lymphocytes and poor prognosis in aged sepsis
por: Inoue, S, et al.
Publicado: (2012)

Correction: Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
por: Stolk, Jan, et al.
Publicado: (2006)

Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
por: Scott, Benjamin M., et al.
Publicado: (2014)

Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
por: Tanaka, Koji, et al.
Publicado: (2002)

Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab
por: Forero, Andres, et al.
Publicado: (2013)

Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2013)

Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients
por: Wang, Zhenyan, et al.
Publicado: (2021)

Proteinases and Tumour Invasion
por: Schor, S.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_5dc2rtn1nb8oh69mnrjctlgof6